Abstract. Previously, alterations in neuronal metabolism were found in a number of brain areas of Alzheimer disease (AD) patients. In the present study we aimed at determining for the first time whether metabolic changes would also occur in vascular dementia (VD) patients in the supraoptic (SON), infundibular (INF), tuberomamillary (TMN), medial mamillary nuclei, vertical limb of the diagonal band of Broca (VDB), and nucleus basalis of Meynert. The Golgi complex (GC) size, cell size, and vasopressin mRNA levels (in the SON) were used as measures of neuronal metabolic activity in postmortem material. The GC immunoreactivity was clearly diminished in the SON, INF and TMN and was increased in the VDB of VD cases. Interestingly, in the SON and TMN, a decrease in the GC size was more pronounced in male than in female VD patients in accordance with the higher prevalence of VD in men. In 7 of 11 VD cases, vasopressin mRNA levels were significantly reduced which may contribute to urinary incontinence, one of the most common clinical symptoms in VD, and to the lower blood pressure values that are often registered at the later stages of the VD. Since the human TMN is the sole source of cerebral histamine, our data suggest deficient histaminergic transmission in the brain in VD. Diminished neuronal metabolism in the SON and INF was not observed in AD in this and previous studies, whereas the changes in the VDB and TMN are similar in VD and AD. In the present study we thus found decreased metabolic activity in several hypothalamic nuclei in VD indicating diminished production of certain hormones and neurotransmitters.
INTRODUCTION
Vascular dementia (VD) is the second most common dementia type after Alzheimer disease (AD) in Western countries and is even more prevalent in the East (1). The incidence of VD is likely to be higher in men and increases with advancing age in both sexes (1) . VD is diagnosed if significant cerebrovascular disease is present that is judged to be causally relevant to the cognitive impairment (1-4), whereas, neuropathologically, the presence of multiple infarcts and absence of Alzheimer changes must be confirmed (2) . Cognitive symptoms in VD are caused by the brain parenchymal lesions of vascular origin that may be produced through ischemia, hemorrhage, or edema resulting in combinations of multiple large infarcts, single strategic infarcts, lacunae, and white matter lesions (4) . Rather than large hemispheral infarcts, small widespread vascular lesions with predominant subcortical localization in the basal ganglia and white matter in strategically important brain regions such as the thalamus and the hippocampus are considered to be central in the VD neuropathology (5) . It was, furthermore, postulated that metabolic consequences of subcortical lesions and their effects on cortical function may play a cardinal role in the manifestations of cognitive impairments and psychiatric disturbances (6) . Possible mechanisms through which focal ischemic lesions may alter functions of other brain areas include edema, disruption of cortical connections, and diaschisis (i.e. reduced metabolic activity of distant but synaptically connected brain areas (4) ). Indeed, a number of magnetic resonance imaging and positron emission tomography studies showed decreased metabolism in the brain of VD patients, also depending on the localization and extent of the ischemic lesions (7) (8) (9) (10) . However, no distinction could be made in this manner between small brain regions or between types of neurons. Furthermore, no data concerning possible VD-related changes in hypothalamic neuroendocrine nuclei and cholinergic basal forebrain were provided. Since AD-related metabolic alterations have been previously described in the hypothalamic and basal forebrain nuclei involved in cognition, that is, the vertical limb of the diagonal band of Broca (VDB), the nucleus basalis of Meynert (NBM), the tuberomammillary (TMN), and medial mamillary (MMN) nuclei using the size of the Golgi complex (GC) and cell size as appropriate measures (11) (12) (13) (14) (15) , the focus of this study was to determine whether metabolic changes would also occur in VD patients. An additional point was to examine the supraoptic (SON) and the infundibular (INF) nuclei. The disturbances in the vasopressin synthesis in the SON may contribute to the urinary incontinence, one of the most common clinical symptoms of VD, and to changes in blood pressure in this group of people (1, 3). As concerns the infundibular nucleus, it is one of the major sources of gonadotropin-releasing hormone (GnRH) and food consumption-regulating neuropeptides in humans, and in AD shows the presence of hyperphosphorylated tau (16, 17) .
As mentioned above, the GC size and cell size were previously reported to be reliable measures of changes in metabolism in different cell types, physiological states, and neurological diseases independent of the neurotransmitter content of the neuron (14) and were, therefore, applied to determine the alterations in neuronal metabolic activity in the present study. In addition to these measures, we have for the first time performed in situ hybridization (ISH) of the vasopressin mRNA in the dorsolateral SON of VD patients.
MATERIALS AND METHODS

Tissue Collection
In order to study VD-related metabolic changes in the VDB, NBM, SON, INF, TMN, and MMN, 11 VD patients (5 men and 6 women, aged 76.9 Ϯ 2.8 years) were matched for age, sex, and fixation time with 11 control subjects (5 men and 6 women, aged 76.7 Ϯ 2.7 years) ( Table 1 ). In addition, a group of 13 AD patients (6 men and 7 women, aged 75.7 Ϯ 2.8 years) was selected to compare neuronal metabolic rates between the VD and AD groups (Table 1) . In all cases, permission for the brain autopsy and the use of the material and clinical information for research purposes was obtained in the framework of the Netherlands Brain Bank. The demented patients were clinically assessed and diagnosed as ''probable VD'' in accordance with the NINCDS-AIREN criteria (18) and as ''probable AD'' following the NINCDS-ADRDA criteria (19) . Controls showed no signs of cognitive impairment, had no history of any neurological or psychiatric disorder, and were confirmed at autopsy by the absence of changes satisfying criteria for any brain disorder. Neuropathological examination of VD patients commonly revealed 1) moderate to severe atherosclerosis of the large basal cerebral vessels; 2) diffusely dilated ventricular system; 3) lacunae; 4) ''old'' and ''recent'' infarctions; 5) necrotic lesions and atrophy of (in some cases entire) gyri and adjacent white matter; 6) multiple hemorrhages and their remnants; 7) rarefaction and maceration of the white matter appearing spotty and loose; and 8) état criblé in the caudate nucleus, putamen, pallidum, and thalamus. Infarctions were observed in the temporal, parietal, occipital and occasionally frontal cortex, in the cingulate gyrus, insula, caudate nucleus, putamen, pallidum, capsula interna and externa, cerebellum, and pons. Vascular pathology included 1) necrosis, fibrosis, and sometimes hyalinosis of the intracerebral blood vessels with tunica media smooth muscle cell loss and replacement by collagen; 2) often hyperplastic/hypertrophic endothelium; 3) infiltration of the tunica media and tunica intima with foam cells; 4) perivascular dilations, edema and (lymphocytic) infiltrates; and 5) occasional reorganizing/recanalizing and congested veins (2, 21) . It is noteworthy that in all VD cases only slight senile involutive changes were present, and Braak stage did not exceed II in contrast to AD patients who had Braak stages for neurofibrillary tangles IV-VI (Table 1) (14, 15, 20, 22) . The hypothalami containing the VDB, NBM, SON, INF, TMN, and MMN were dissected, fixed in 4% formaldehyde in phosphate-buffered saline (pH 7.4) at room temperature, dehydrated in graded ethanols, embedded in paraffin, and cut serially in 6-m frontal sections. For anatomical orientation, every fiftieth section was mounted on chrome-aluminum sulphate-coated glass slides, deparaffinized, hydrated, and stained with thionine (0.5%).
Immunocytochemical staining of the GC was performed and evaluated in the core of 1) the VDB, located rostral to the hypothalamus at the level of the nucleus accumbens where it occupies a position along the medial aspect of the brain (14); 2) the NBM (i.e. ventral intermediate subdivision of the Ch4 (11)); 3) the major dorsolateral part of the SON located behind or dorsolaterally to the optic tract (16); 4) the INF (16); 5) the major ventral part of the TMN, a magnocellular cluster in the tuberal and posterior hypothalamus, corresponding to the classical TMN (16); and 6) the MMN that forms the caudal border of the hypothalamus and can be easily delineated due to a fiber capsule (15, 16) (Fig. 1) . Immunocytochemical procedure and specificity of the antibody recognizing the medial cisternae of the human neuronal GC (130 kD) have been extensively documented previously (14, 15, 23) .
In Situ Hybridization of Vasopressin mRNA
Two sections per patient containing the SON and PVN were deparaffinized and rehydrated to phosphate buffered saline (PBS) (pH 7.6), treated with 0.2 N HCl for 20 min, and subsequently with 10 g/ml Proteinase K (PK) (Sigma, St. Louis, MO) in the PK buffer (10 mmol/L Tris, 2 mM CaCl 2 ) at 37ЊC for 15 min. Further slides were rinsed in glycine buffer (2 mg/ ml PBS), washed in PBS twice, and delipidated in 0.1% Triton X-100 in PBS solution.
Two pmol of the vasopressin probe (kindly donated by Dr. G. Mengod and Dr. J.M. Palacios, Sandoz Research Laboratories, Basel, Switzerland), which consisted of 48 nucleotides complementary to bases 411-458 of the preprovasopressin precursor (24, 25) , was 3Јend-labeled with 2 l of [␣- 35 S] dATP (Perkin-Elmer Life and Analytical Sciences, Boston, MA) using terminal deoxynucleotidyl transferase (Roche, Mannheim, Germany) and purified by ethanol precipitation. The labeled probe was diluted in hybridization buffer containing 50% de-ionized formamide (Merck, Darmstadt, Germany), 0.5 mol/L NaCl, 10 mmol/L Tris-HCl (pH 7.5), 1 mmol/L EDTA, 1xDenhardt's, 500 g/ml yeast tRNA, 10% dextran sulphate, and 200 mmol/ L DTT. Seventy l of the reconstituted probe in hybridization buffer containing a total of 1 million cpm was added to every section and hybridized at 42ЊC overnight. The following day, sections were washed in 1ϫ SSC for 30 min at 50ЊC, 2ϫ 15 min in 0.1ϫ SSC at 50ЊC, and 2ϫ 15 min in 0.1ϫ SSC at room temperature, dehydrated in 1:1, 3:7, 1:9, and 0:1 300 mmol/L ammonium acetate/100% ethanol mixture solutions for 1 min each and dried in a stream of cool air. Autoradiographic detection was performed by exposure to the highly sensitive film Biomax MR-1 (Eastman Kodak Company, Rochester, NY) overnight. Subsequently, slides were dipped in emulsion diluted 1:1 with distilled water at 42ЊC (NTB 2 , Eastman Kodak Company, Rochester, NY), dried for 1 hour, exposed for 3 days, developed, fixed, and rinsed at 15ЊC, counterstained with thionine, dehydrated and coverslipped with Entellan (Merck, Darmstadt, Germany). To test the specificity of the probe, 2 sections The intensity of the GC immunocytochemical staining and ISH signal was estimated semiquantitatively using light microscopy according to the following scale: ϩϩϩϩ (very strong); 
Quantification
Intensity of the GC immunocytochemical staining and ISH signal was estimated semiquantitatively using light microscopy.
Image Analysis
Measurement of the GC and cell surface was performed in the VDB, SON, INF, and TMN (131 Ϯ 25 neurons per patient) using an IBAS-KAT image analysis system (Kontron, Munich, Germany), connected to a SONY XC-77CE black and white CCD camera mounted on a Zeiss microscope (Zeiss, Munich, Germany) as described earlier (11, 14, 23 
Abbreviations: GC, Golgi complex; VDB, the vertical limb of the diagonal band of Broca; NBM, the nucleus basalis of Meynert; SON, the supraoptic nucleus; INF, the infundibular nucleus; TMN, the tuberomammillary nucleus; MMN, the medial mamillary nucleus; VD, vascular dementia; AD, Alzheimer disease; F, female; M, male; ↑, increase;
↓, decrease; ϭ, no change.
was used for vasopressin mRNA quantification to determine the area (%) of the SON covered with silver grains (25) .
Statistical Methods
Differences in the intensity of the GC staining and vasopressin mRNA ISH signal expressed in arbitrary units and in the GC size, cell size, and the percentage of SON area covered with silver grains measured using the IBAS in the VD, AD, and control groups were tested using the Mann-Whitney U-test and ANOVA. In order to check for correlations between different parameters, linear regression analysis (Spearman test) was applied. A p value Ͻ0.05 was considered to be significant.
RESULTS
Golgi complex (GC) staining resulted in a granular pattern with predominant accumulation of immunoreactivity (GC-ir) around the nucleus (Figs. 2, 3 ). Clear differences in the intensity of the GC immunostaining in the VDB, SON, INF and TMN nuclei in VD were already apparent at the microscopical examination at both low and high magnification, i.e. less intense GC-ir compared to controls in the SON, INF and TMN and more GC-ir in the VDB ( Table 2) . The GC and cell size were subsequently measured in these brain areas of VD and control patients using the IBAS (Table 3) . It is noteworthy here that neither fixation duration nor postmortem time appeared to influence the intensity of immunolabeling and quantitative parameters (i.e. GC and cell size). Since in the previous studies the GC size, cell size, and vasopressin (VP) mRNA levels had already been measured in the same brain areas of AD patients that were under present investigation (11) (12) (13) (14) (15) 24) , only semiquantitative evaluation of the GC-ir was performed in the AD group. The ISH signal of the VP mRNA was clearly reduced in most of the VD cases (Fig. 4) .
GC and Cell Size in the VDB
Intensity of the GC immunostaining (p ϭ 0.035), the GC size (p ϭ 0.002), the cell size (p ϭ 0.026), and the GC/cell size ratio (p ϭ 0.007) were significantly higher in VD than in control patients and there was a trend toward a similar increase in the GC-ir in AD (p ϭ 0.065) ( Fig. 2; Tables 2, 3 ). Moreover, in AD the GC-ir was negatively related to Braak stages (r ϭ Ϫ0.836; p ϭ 0.038). Both the GC size (r ϭ 0.750; p ϭ 0.052) and cell size (r ϭ 0.929; p ϭ 0.003) increased during aging in controls.
GC in the NBM
No differences in the GC-ir were noted in the NBM between VD cases and controls (p ϭ 0.512) or between VD and AD patients (p ϭ 0.949) ( Table 2) .
GC and Cell Size in the SON
The GC tended to be smaller (p ϭ 0.085), and the cell size was larger (p ϭ 0.032) in VD cases compared to ; Ratio, GC/cell size ratio, %; VDB, the vertical limb of the diagonal band of Broca; SON, the supraoptic nucleus; INF, the infundibular nucleus; TMN, the tuberomamillary nucleus; ↑, increase; ↓, decrease; ϭ, no change. controls. Such opposite changes led to a significant decrease in the GC/cell size ratio (p ϭ 0.001) and to a lower intensity of the GC immunostaining (p ϭ 0.016) in the VD group (Tables 2, 3 ). No differences in the intensity of the GC-ir were found between AD and control subjects or between AD and VD patients. Following splitting into males and females, a significant decrease in the GC size (p ϭ 0.032) and the GC/cell size ratio (p ϭ 0.016) of the SON neurons was found only in male and not in female (p ϭ 0.394 and p ϭ 0.093, respectively) VD cases (Fig.  5) . In the VD group, cell size was diminishing with advancing age (r ϭ Ϫ0.692; p ϭ 0.018) and the GC/cell size ratio was reduced when urinary incontinence was present (r ϭ Ϫ0.671; p ϭ 0.024).
GC and Cell Size in the INF
A clearly lower GC-ir (p ϭ 0.021), GC size (p ϭ 0.027), and GC/cell size ratio (p ϭ 0.027) were observed in the INF neurons of the VD than in control patients, whereas no differences between AD and control subjects were apparent (p ϭ 0.395) ( Tables 2, 3 ). It is noteworthy that in AD the GC-ir was positively related to APOE genotype (r ϭ 0.918; p ϭ 0.030).
GC and Cell Size in the TMN
A clearly smaller neuronal GC size was found in the TMN of VD cases compared to controls both at the microscopical level (p ϭ 0.001) and following IBAS measurements (p ϭ 0.005) ( Fig. 3; Tables 2, 3 ). No changes in the cell size were observed in VD (p ϭ 0.152), whereas the GC/cell size ratio was decreased (p ϭ 0.010). Following splitting into men and women, a more prominent diminishment in the TMN neuronal GC size was found in VD males (p ϭ 0.027) than in VD females (p ϭ 0.053) (Fig. 5) . Intensity of the GC immunostaining was lower in AD than in control cases (p ϭ 0.013) and no differences between VD and AD cases were thus present (p ϭ 0.193). Furthermore, a more prominent decrease in the GC immunostaining was noted in female AD patients (p ϭ 0.026) compared to males (p ϭ 0.286).
GC in the MMN
Intensity of the GC staining in the MMN did not differ between VD and control patients (p ϭ 0.351) or AD and control subjects (p ϭ 0.400) as also shown earlier (15) or between VD and AD cases (p ϭ 0.887) ( Table 2) . Regarding the VD group, female patients showed more intensive GC-ir than males (p ϭ 0.036) in accordance with the activation of the MMN neurons in women during aging (15) . It is of interest that the GC-ir did not significantly differ between VD and AD patients in either of the nuclei studied, except for a trend in the SON where VD cases showed less intense GC staining (p ϭ 0.065) ( Table 2) .
ISH of the Vasopressin mRNA in the SON
No significant differences in VP mRNA levels were detected in the SON of the vascular dementia group compared to their matched controls as judged from the percentage of the SON area covered with silver grains (p ϭ 0.557) and from the intensity of the ISH signal per neuron (p ϭ 0.114). However, significantly reduced VP mRNA levels were detected in the SON of 7 VD patients (p ϭ 0.021 for the percentage area and p ϭ 0.002 for the intensity) ( Fig. 4; Table 1 ). This selection was based on the localization and extension of the neuropathology in VD and exclusion of prolonged postmortem delay and fixation time in controls as potential factors influencing mRNA expression (see Discussion). Furthermore, in the 6 VD cases VP mRNA levels were positively related to diastolic blood pressure (r ϭ 0.893; p ϭ 0.016) and in 2 of them to both systolic and diastolic blood pressure (r ϭ 1.000; p ϭ 0.0001). Although quantification was performed only in the SON, similar qualitative differences in arginine-vasopressin (AVP) mRNA levels were observed in the paraventricular nucleus.
DISCUSSION
In the present study we found for the first time, diminished neuronal metabolic activity in the SON, INF, and TMN nuclei of VD cases. In contrast, an increase in both the GC and cell size that are indicative for enhanced neuronal metabolic activity (13, 14) was determined in the VDB. No changes in the GC-ir were observed in the NBM or the MMN. These findings may be associated with a reduction of the cerebral blood flow caused by ischemic lesions and vascular pathology in VD patients. Variability in metabolic alterations in VD cases as also noticeable from the present study might depend on 1) differences in the localization and extent of ischemic lesions, while subcortical damage seems to have a major pathogenetic role (26) , and 2) the severity score of dementia (ranging from Reisberg scale 3 to 7) that was shown to be significantly related to the total volume of metabolically inactive tissue (7) . It is of interest that a decrease in the neuronal metabolism in the SON and TMN was more pronounced in male than in female VD cases in agreement with a higher prevalence of VD in men (1) . This finding might also be explained by the possible sex differences in the size of the white matter damage. In contrast to AD (more prevalent in women), in VD patients white matter lesions often dominate gray matter changes (27) . Taken together with reported larger volumes of white matter in men than in women (28) , these facts may point to a relative excess of the brain tissue damage in VD males. Given the specific neurohormonal and neurotransmitter content of the brain areas under investigation, the observed metabolic alterations may have clear functional consequences.
The vertical limb of the diagonal band of Broca and the nucleus basalis of Meynert are major cholinergic basal forebrain nuclei. The VDB mainly projects to the hippocampus, whereas the NBM projects to the cortex (29) . Unexpectedly, we did not find any evidence for a cholinergic deficit in vascular dementia as was suggested by a number of studies (30) (31) . On the contrary, even increased metabolic activity was noted in the VDB of VD cases. There is, however, also an age-dependent activation of the VDB neurons in AD (14) , an observation that was replicated in the present study. Moreover, in AD the VDB GC-ir was negatively related to Braak stages confirming the idea of a compensatory role of the activation of the cholinergic neurons at earlier progression of dementia (13, 14, 32) . In concordance with the previous finding (14) the GC size and cell size increased during aging in the VDB of controls. As concerns the absence of a difference in the GC-ir in the NBM, it agrees well with a lack of significant changes in choline acetyltransferase activity in the brain tissue from vascular dementia patients (33) .
The human supraoptic nucleus is 90% to 95% vasopressinergic and is the major production site of plasma vasopressin (VP), which is mainly involved in the regulation of water reabsorption, plasma osmolality, and blood pressure (16) . VP secretion is generally not affected in demented patients including AD (16, 17) , but nothing in particular was known about VP production in VD. Interestingly, lower plasma and CSF VP concentrations were measured in patients with primary degenerative dementia in the study of Sørensen et al (34) , although the dementia type was not clarified. This observation may support our findings of decreased VP neuronal metabolic activity and VP mRNA levels in most of the VD patients. Consequently, the impaired release of VP may contribute to urinary incontinence and to lower blood pressure values in later stages of the VD. In our study, indeed, the relative size of the Golgi complex in the SON of VD cases was smaller when urinary incontinence was present. Furthermore, vasopressin mRNA levels were attenuated when a lower diastolic blood pressure was registered. In this respect it is of interest, that according to the clinical records of VD patients who had hypertension in the past, blood pressure values were often found to decrease when dementia was progressing, which is in line with the literature (1, 3) .
The heterogeneity of the VD neuropathology could account for the absence of differences in VP mRNA levels in the whole VD cohort (Table 1) . For instance, in the VD case #4 only micro-infarctions were present in the cortex and no subcortical lesions were observed. Similarly, the prevalence of ''old'' cortical infarctions may be a reason for the higher VP mRNA levels in the VD case #9. Therefore, ''old'' cortical infarctions might have a little effect on or even stimulate VP mRNA levels, whereas ''recent'' and subcortical lesions may contribute to a significant decrease in VP synthesis. Such data support the notion that subcortical vascular damage is central to the pathogenesis of VD and is a prime substrate for much of the cerebral damage relevant in this disorder (26, 36) . Furthermore, an activation of the VP synthesis in VD patients could be caused by traumatic brain injury in cases #9 and #5 and a meningioma at the base of the brain in case #5 (35) . In addition, the possibility of confounding factors of some of the controls (i.e. cases #3, #6, and #9) influencing mRNA levels in postmortem tissue can not be excluded. On average, controls had a larger postmortem delay than VD cases (p ϭ 0.023) that tended to be negatively related to the VP mRNA levels (r ϭ Ϫ0.565; p ϭ 0.089). Despite this fact, they still had overall higher VP mRNA ISH signal than VD patients, strengthening the idea of decreased vasopressin production in most of the VD cases.
A trend for an enlarged cell size of the SON neurons was a surprising finding, as it seemed at first glance not to support a reduction in the VP neuronal metabolism. However, light and fluorescent microscopical examination revealed abundant peripheral lipofuscin accumulations in the SON neurons of VD cases that may not only explain the increase in cell size, but also might be a sign of the attenuation of the functional activity of the VP neurons (16, 17) .
The human tuberomamillary nucleus is the sole source of histaminergic innervation of the brain (16) . While decreased TMN neuronal metabolic activity and brain histamine content were reported in AD cases (12, 13) , no such data in VD were available. Our results show for the first time diminished metabolic activity of histaminergic neurons in the TMN of VD patients and similarly to AD suggest a histaminergic deficit in vascular dementia. It is plausible that the reduced activity of the histaminergic system in VD may be related to the attenuated metabolism of the VP neurons in the SON (see above) since histamine is a potent releaser of vasopressin (16) .
The decreased metabolic activity of the infundibular nucleus neurons in VD patients seen in the present study may be related to a lower secretion of the gonadotropinreleasing hormone (GnRH) and other INF neuropeptides, for example, related to eating behavior like NPY and agouti-related protein (AGRP) (17, 37) . There was a trend toward decreased GC immunostaining in the VD group when compared to the AD group. However, this decrease did not achieve statistical significance for any of the nuclei studied. These results support the data from proton magnetic resonance spectroscopy (10) and positron emission tomography (7) showing a considerable overlap in metabolic impairments in these two most common dementias. However, in comparison with controls, the GC-ir in VD differs from AD in the nucleus basalis of Meynert (no change in VD and a decrease in AD), in the supraoptic and in the infundibular nuclei (a reduction in VD and no change in AD).
In summary, we found for the first time neuronal metabolic alterations in the hypothalamus and basal forebrain of vascular dementia patients partly overlapping with those in Alzheimer disease. Although the exact reasons for these findings are uncertain, they are proposed to be due to reduced cerebral blood flow and to depend on extension and localization of ischemic brain lesions and vascular pathology. The deficiency of histaminergic system originating from the TMN and the diminished vasopressin supply from the supraoptic nucleus may contribute to frequent symptoms observed in vascular dementia such as cognitive decline, urinary incontinence, and lower blood pressure.
